Tread Strong: Support BIDMC's 2018 Boston Marathon Team
MARCH 05, 2018
After delivering a healthy baby boy, Noemi was forced to focus on her own health. She was diagnosed with Alport Syndrome, a genetic condition characterized by progressive kidney disease, hearing loss and eye abnormalities. Almost all of the women on her maternal side of the family have Alport Syndrome, although at different degrees of severity. Side effects involving blood and high levels of protein in the urine can eventually result in loss of kidney function.
But Noemi refuses to let this diagnosis define her. A New Jersey native with an interest in running, she found Team BIDMC online and was determined to be a part of it so that she could help raise money for kidney disease research. “I’m running in honor of each and every one of my family members who suffers from Alport Syndrome,” Noemi said. “We may live with this incurable disease but we will not let it direct our path.”
Noemi is one of 63 Team BIDMC runners who will trek 26.2 miles on April 16. Funds raised in honor of Noemi will benefit kidney disease research led by Martin Pollak, MD. Read more about Noemi’s journey and support Team BIDMC.
About Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School and consistently ranks as a national leader among independent hospitals in National Institutes of Health funding. BIDMC is the official hospital of the Boston Red Sox.
Beth Israel Deaconess Medical Center is a part of Beth Israel Lahey Health, a health care system that brings together academic medical centers and teaching hospitals, community and specialty hospitals, more than 4,000 physicians and 35,000 employees in a shared mission to expand access to great care and advance the science and practice of medicine through groundbreaking research and education.